home / stock / immp / immp news


IMMP News and Press, Immutep Limited

Stock Information

Company Name: Immutep Limited
Stock Symbol: IMMP
Market: NASDAQ
Website: immutep.com

Menu

IMMP IMMP Quote IMMP Short IMMP News IMMP Articles IMMP Message Board
Get IMMP Alerts

News, Short Squeeze, Breakout and More Instantly...

IMMP - Immutep Receives Regulatory Clearance for Phase I Study of First-in-Class LAG-3 Agonist Antibody Designed to Treat Autoimmune Diseases

Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing no...

IMMP - Immutep: Positive Efti Treatment Data Leads To Late-Stage Programs

2024-07-15 13:54:02 ET Summary Immutep Limited achieved positive results in the phase 2b study, using efti + Keytruda for the treatment of patients with 1st-line head and neck squamous cell carcinoma; Both PD-L1 positive and negative patients. Company to meet with FDA to be in a p...

IMMP - QS, SWN, IMMP, KEY, NCLH showing five-day upward surge

2024-07-12 10:45:04 ET QuantumScape Corp (QS) QS is trading UP for the last 5 days, and it at trading at $7.84 with volume of 22,322,158 and a one day change of $0.78 (10.98%). QuantumScape Corp has a 52-week low of 4.67 and a 52-week high of $13.86. The business's 50-day moving ave...

IMMP - Biggest stock movers today: TSLA, ERIC, and more

2024-07-12 05:19:20 ET More on related stocks: Tesla: Up +62% From Our Prior Bullish Article - Is It Time To Protect? (Technical Analysis) Wall Street Lunch: Tesla's Big Bull Run Surging Stock, Struggling Core: Tesla's Mixed Signals To Investors Tesla unveils...

IMMP - Immutep gains after positive results from cancer trial

2024-07-12 04:59:07 ET More on Immutep Immutep: Realizing The Expected Catalysts, With More To Come Immutep slips after stock offering Immutep reports promising efti/Keytruda data for head and neck cancer Seeking Alpha’s Quant Rating on Immutep ...

IMMP - Immutep Reports Positive Results in First Line Head and Neck Squamous Cell Carcinoma Patients with Negative PD-L1 Expression

Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST 1.1, among the highest recorded for a treatment approach not containing chemotherapy in patients with CPS <1 High complete response...

IMMP - Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results

Company to Host Webcast on 12th July at 9am AEST (7pm ET, 11 July) SYDNEY, AUSTRALIA, July 03, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immu...

IMMP - US Companies Moving the Markets, Evening edition
Thu, Jun 27, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...

IMMP - US Companies Moving the Markets, Morning edition
Thu, Jun 27, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 20.9% to $0.5541 on volume of 173,316,620 shares Assure Holdings Corp. (IONM) rose 114.1% to $0.496799 on volume of 118,668,589 shares NLS Pharmaceutics Ltd. (NLSP) rose 67.6% to $0...

IMMP - IMMP Price Target Alert: $6.00. Issued by Robert W. Baird

2024-06-27 08:00:12 ET Joel Beatty from Robert W. Baird issued a price target of $6.00 for IMMP on 2024-06-27 06:42:00. The adjusted price target was set to $6.00. At the time of the announcement, IMMP was trading at $2.77. The overall price target consensus is at $10.00...

Next 10